Eileen Lenoy

922 total citations
9 papers, 770 citations indexed

About

Eileen Lenoy is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Eileen Lenoy has authored 9 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Eileen Lenoy's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Eileen Lenoy is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Eileen Lenoy collaborates with scholars based in United States, Japan and Canada. Eileen Lenoy's co-authors include Eric R. Jensen, Sarkis K. Mazmanian, Olaf Schneewind, Peter J. Petersen, Jason Weiss, R. Thomas Williamson, Guy T. Carter, Jason Lotvin, Guy Singh and Marshall M. Siegel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Eileen Lenoy

9 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Lenoy United States 8 601 206 191 186 103 9 770
Anatoly Severin United States 16 516 0.9× 121 0.6× 323 1.7× 208 1.1× 125 1.2× 24 981
Guy Singh United States 13 523 0.9× 189 0.9× 133 0.7× 381 2.0× 37 0.4× 16 856
Jianlan You United States 16 326 0.5× 267 1.3× 112 0.6× 86 0.5× 61 0.6× 23 833
Alfonso Mendoza Spain 14 323 0.5× 56 0.3× 181 0.9× 70 0.4× 144 1.4× 23 846
Jean‐Paul Brouard France 12 379 0.6× 66 0.3× 188 1.0× 74 0.4× 32 0.3× 27 688
Srinivas Kodali United States 9 271 0.5× 206 1.0× 126 0.7× 162 0.9× 92 0.9× 12 618
Jichan Jang South Korea 19 499 0.8× 135 0.7× 494 2.6× 178 1.0× 21 0.2× 43 1.0k
Ute Moellmann Germany 11 216 0.4× 80 0.4× 55 0.3× 160 0.9× 28 0.3× 17 569
J N Hobbs United States 17 539 0.9× 224 1.1× 340 1.8× 124 0.7× 44 0.4× 18 980
Gianpaolo Candiani Italy 10 314 0.5× 198 1.0× 205 1.1× 100 0.5× 19 0.2× 11 605

Countries citing papers authored by Eileen Lenoy

Since Specialization
Citations

This map shows the geographic impact of Eileen Lenoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Lenoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Lenoy more than expected).

Fields of papers citing papers by Eileen Lenoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Lenoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Lenoy. The network helps show where Eileen Lenoy may publish in the future.

Co-authorship network of co-authors of Eileen Lenoy

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Lenoy. A scholar is included among the top collaborators of Eileen Lenoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Lenoy. Eileen Lenoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Venkatesan, Aranapakam M., Atul Agarwal, Takao Abé, et al.. (2004). Novel imidazole substituted 6-methylidene-penems as broad-spectrum β-lactamase inhibitors. Bioorganic & Medicinal Chemistry. 12(22). 5807–5817. 31 indexed citations
2.
Dushin, Russell G., Tingzhong Wang, Haiyin He, et al.. (2004). Hydrophobic Acetal and Ketal Derivatives of Mannopeptimycin-α and Desmethylhexahydromannopeptimycin-α:  Semisynthetic Glycopeptides with Potent Activity Against Gram-Positive Bacteria. Journal of Medicinal Chemistry. 47(14). 3487–3490. 32 indexed citations
3.
Weiss, Jason, et al.. (2004). In Vivo Efficacy and Pharmacokinetics of AC98-6446, a Novel Cyclic Glycopeptide, in Experimental Infection Models. Antimicrobial Agents and Chemotherapy. 48(5). 1708–1712. 19 indexed citations
4.
Sum, Phaik‐Eng, et al.. (2003). Novel ether derivatives of mannopeptimycin glycopeptide antibiotic. Bioorganic & Medicinal Chemistry Letters. 13(6). 1151–1155. 18 indexed citations
5.
Singh, Manpreet, P. J. Petersen, Jason Weiss, et al.. (2002). Mannopeptimycins, New Cyclic Glycopeptide Antibiotics Produced by Streptomyces hygroscopicus LL-AC98: Antibacterial and Mechanistic Activities. Antimicrobial Agents and Chemotherapy. 47(1). 62–69. 99 indexed citations
6.
McDonald, Leonard A., Laurel R. Barbieri, Guy T. Carter, et al.. (2002). Structures of the Muraymycins, Novel Peptidoglycan Biosynthesis Inhibitors.. ChemInform. 33(52). 217–217. 1 indexed citations
7.
McDonald, Leonard A., Laurel R. Barbieri, Guy T. Carter, et al.. (2002). Structures of the Muraymycins, Novel Peptidoglycan Biosynthesis Inhibitors. Journal of the American Chemical Society. 124(35). 10260–10261. 174 indexed citations
8.
Mazmanian, Sarkis K., et al.. (2000). Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proceedings of the National Academy of Sciences. 97(10). 5510–5515. 382 indexed citations
9.
Bitha, Panayota, Zhong Li, Gerardo D. Francisco, et al.. (1999). 6-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C β-lactamases II. Bioorganic & Medicinal Chemistry Letters. 9(7). 997–1002. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026